Table 3.

Univariate and Multivariable Patient Survival

Variable [Reference group]		Univariate patient survival HR (95% CI)	p-value	Multivariable patient survival HR (95% CI)	p-value
RECIPIENT FACTORS
Age		1.03 (1.02–1.04)	<0.001	1.02 (1.01–1.03)	<0.001
Male [female]		1.30 (1.05–1.61)	0.015	1.34 (1.07–1.67)	0.010
Non-caucasian [Caucasian]		1.20 (0.97–1.49)	0.093	1.08 (0.86–1.34)	0.52
Indication for LT:
HCC [non-HCC]		1.67 (1.34–2.08)	<0.001	1.17 (0.90–1.51)	0.23
HCV [non-HCV]		1.24 (1.00–1.53)	0.048	1.13 (0.92–1.40)	0.25
HBV [non-HBV]		0.73 (0.45–1.17)	0.19
BMI at LT:
<19 [22 to 25]		0.82 (0.53–1.27)	0.36
19 to 21 [22 to 25]		1.14 (0.92–1.41)	0.25
Delta BMI		0.89 (0.87–0.93)	<0.001	0.89 (0.86–0.92)	<0.001
Diabetes		1.36 (1.07–1.73)	0.013	1.22 (0.96–1.56)	0.11
MELD at LT		0.98 (0.97–1.00)	0.014	1.00 (0.98–1.01)	0.50
Dialysis in week prior to LT		1.01 (0.68–1.51)	0.95
Hospitalization within 90 days of LT		1.03 (0.77–1.37)	0.84
Mechanical Ventilator		0.57 (0.28–1.14)	0.11
Rejection in 1st year post-LT		1.12 (0.84–1.50)	0.44
DONOR FACTORS
Age		1.02 (1.01–1.02)	<0.001	1.01 (1.01–1.02)	<0.001
Male [female]		0.87 (0.72–1.07)	0.19
Non-caucasian [Caucasian]		1.27 (1.03–1.57)	0.028	1.24 (1.00–1.54)	0.055
Height		0.99 (0.98–1.00)	0.061	0.99 (0.98–1.00)	0.24
Weight		1.00 (0.99–1.01)	0.90
BMI		1.02 (0.99–1.04)	0.17
DCD Allograft		1.13 (0.71–1.80)	0.60
Cold ischemia time		1.02 (1.00–1.05)	0.11
Partial or Split Liver Allografta		0.41 (0.25–0.68)	<0.001
Deceased [Living Donor Allograft]		2.64 (1.45–4.81)	0.002	2.31 (1.25–4.24)	0.007

^aCorrelated with living donor, so not included in the multivariable model